German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L04AF" (16)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Tofacitinib (L04AF01) 13 products
WHO-DDD
L
IP
CI
Xeljanz 5 mg
56 Tablet(s)
410.28
460.30
10 %
Coated tablets: Tofacitinibum 5 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Xeljanz 10 mg
56 Tablet(s)
690.40
763.40
10 %
Coated tablets: Tofacitinibum 10 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Tofacitinib Devatis 10 mg
56
627.64
699.00
10 %
Coated tablets: Tofacitinibum 10 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Tofacitinib Sandoz 5 mg
56
372.99
422.05
10 %
Coated tablets: Tofacitinibum 5 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Tofacitinib Sandoz 10 mg
56
627.64
699.00
10 %
Coated tablets: Tofacitinibum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
Tofacitinib Spirig HC 5 mg
56
k.A.
Coated tablets: Tofacitinibum 5 mg
Spirig HealthCare AG
B
FB
G
Tofacitinib Spirig HC 10 mg
56
k.A.
Coated tablets: Tofacitinibum 10 mg
Spirig HealthCare AG
B
FB
G
Tofacitinib-Mepha 5 mg
56
k.A.
Coated tablets: Tofacitinibum 5 mg
Mepha Pharma AG
B
FB
G
Tofacitinib-Mepha 5 mg
60
k.A.
Coated tablets: Tofacitinibum 5 mg
Mepha Pharma AG
B
FB
G
Tofacitinib-Mepha 5 mg
60
k.A.
Coated tablets: Tofacitinibum 5 mg
Mepha Pharma AG
B
FB
G
Tofacitinib-Mepha 10 mg
56
k.A.
Coated tablets: Tofacitinibum 10 mg
Mepha Pharma AG
B
FB
G
Tofacitinib-Mepha 10 mg
60
k.A.
Coated tablets: Tofacitinibum 10 mg
Mepha Pharma AG
B
FB
G
Tofacitinib-Mepha 10 mg
60
k.A.
Coated tablets: Tofacitinibum 10 mg
Mepha Pharma AG
B
FB
G
Upadacitinib (L04AF03) 2 products
WHO-DDD
L
IP
CI
Rinvoq 30 mg
28
765.24
848.65
10 %
Delayed release tablets: Upadacitinibum 30 mg
AbbVie AG
B / SL
FB
G
L
IP
CI
Rinvoq 45 mg
28
1744.75
1913.95
10 %
Delayed release tablets: Upadacitinibum 45 mg
AbbVie AG
B / SL
FB
G
Ritlecitinib (L04AF08) 1 products
WHO-DDD
IP
CI
Litfulo 50 mg
30
k.A.
Capsules: Ritlecitinibum 50 mg
Pfizer AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
